Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Modeling the Effects of Morphine-Altered Virus Specific Antibody Responses on HIV/SIV Dynamics.

Tytuł:
Modeling the Effects of Morphine-Altered Virus Specific Antibody Responses on HIV/SIV Dynamics.
Autorzy:
Mutua JM; Department of Computer Science, Mathematics and Physics, Missouri Western State University, St. Joseph, Missouri, USA.
Perelson AS; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, New Mexico, USA.
Kumar A; Division of Pharmacology, School of Pharmacy, University of Missouri - Kansas City, Missouri, USA.
Vaidya NK; Department of Mathematics and Statistics, San Diego State University, San Diego, California, USA. .; Computational Science Research Center, San Diego State University, San Diego, California, USA. .; Viral Information Institute, San Diego State Universtiy, San Diego, California, USA. .
Źródło:
Scientific reports [Sci Rep] 2019 Apr 01; Vol. 9 (1), pp. 5423. Date of Electronic Publication: 2019 Apr 01.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Język:
English
Imprint Name(s):
Original Publication: London : Nature Publishing Group, copyright 2011-
MeSH Terms:
Antibodies, Viral/*immunology
Antibody Formation/*drug effects
HIV Infections/*immunology
Morphine/*pharmacology
Simian Acquired Immunodeficiency Syndrome/*immunology
Simian Immunodeficiency Virus/*immunology
Algorithms ; Analgesics, Opioid/pharmacology ; Animals ; Antibody Formation/immunology ; CD4-Positive T-Lymphocytes/drug effects ; CD4-Positive T-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/virology ; HIV Infections/virology ; Humans ; Macaca mulatta ; Male ; Models, Theoretical ; Simian Acquired Immunodeficiency Syndrome/virology ; Simian Immunodeficiency Virus/physiology ; Virus Replication/drug effects ; Virus Replication/immunology
References:
Front Microbiol. 2018 Jun 20;9:1326. (PMID: 29973924)
Virology. 2006 Oct 10;354(1):192-206. (PMID: 16876224)
Lancet. 1999 Nov 20;354(9192):1782-5. (PMID: 10577640)
J Virol. 2010 May;84(9):4302-10. (PMID: 20147390)
J Virol. 2008 Dec;82(24):12449-63. (PMID: 18842730)
PLoS Comput Biol. 2016 Sep 26;12(9):e1005127. (PMID: 27668463)
BMC Biol. 2013 Sep 03;11:96. (PMID: 24020860)
J Virol. 2009 Apr;83(7):3288-97. (PMID: 19129448)
J Virol. 1997 Oct;71(10):7518-25. (PMID: 9311831)
Math Biosci. 2002 Nov-Dec;180:29-48. (PMID: 12387915)
J Virol. 2003 Apr;77(8):5037-8. (PMID: 12663814)
AIDS Res Treat. 2012;2012:953678. (PMID: 22666564)
Science. 1998 Feb 20;279(5354):1223-7. (PMID: 9469816)
J Theor Biol. 2000 Apr 7;203(3):285-301. (PMID: 10716909)
J Neuroimmunol. 1998 Mar 15;83(1-2):77-87. (PMID: 9610676)
Virology. 2018 Jan 1;513:108-113. (PMID: 29055819)
Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):5467-72. (PMID: 25870266)
PLoS Comput Biol. 2014 Jul 31;10(7):e1003730. (PMID: 25078553)
J Virol. 1999 Jan;73(1):855-60. (PMID: 9847402)
Cold Spring Harb Perspect Med. 2012 Jan;2(1):a007039. (PMID: 22315717)
Clin Microbiol Rev. 2003 Apr;16(2):209-19. (PMID: 12692094)
J Exp Med. 1999 Sep 20;190(6):841-50. (PMID: 10499922)
Science. 1996 Jan 26;271(5248):497-9. (PMID: 8560262)
Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19079-84. (PMID: 18025463)
Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6971-6. (PMID: 9192676)
Nat Rev Immunol. 2002 Jan;2(1):28-36. (PMID: 11905835)
AIDS. 1994 Mar;8(3):339-43. (PMID: 7913328)
PLoS One. 2012;7(2):e31167. (PMID: 22359571)
J Virol. 2004 Oct;78(20):11425-8. (PMID: 15452267)
Grant Information:
R01 OD011095 United States OD NIH HHS; DA015013 International U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA); R01 AI028433 United States AI NIAID NIH HHS; R01 AI104373 United States AI NIAID NIH HHS
Substance Nomenclature:
0 (Analgesics, Opioid)
0 (Antibodies, Viral)
76I7G6D29C (Morphine)
Entry Date(s):
Date Created: 20190402 Date Completed: 20201005 Latest Revision: 20210109
Update Code:
20240104
PubMed Central ID:
PMC6443976
DOI:
10.1038/s41598-019-41751-8
PMID:
30931971
Czasopismo naukowe
Drugs of abuse, such as opiates, have been widely associated with enhancing HIV replication, accelerating disease progression and diminishing host-immune responses, thereby making it harder to effectively manage HIV infection. It is thus important to study the effects of drugs of abuse on HIV-infection and immune responses. Here, we develop mathematical models that incorporate the effects of morphine-altered antibody responses on HIV/SIV dynamics. Based on fitting the model to experimental data from simian immunodeficiency virus (SIV) infections in control and morphine-addicted macaques, we found that two of the most significant effects of virus specific antibodies are neutralizing viral particles and enhancing viral clearance. Using our model, we quantified how morphine alters virus-specific antibody responses, and how this alteration affects the key components of virus dynamics such as infection rate, virus clearance, viral load, CD4 + T cell count, and CD4 + T cell loss in SIV-infected macaques under conditioning with morphine. We found that in a subpopulation of SIV-infected morphine addicted macaques, the presence of drugs of abuse may cause significantly diminished antibody responses, resulting in more severe infection with increased SIV infectivity, a decreased viral clearance rate, increased viral load, and higher CD4 + T cell loss.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies